Kamal Adawi

Currently holds a position at Exagen Inc

Position	Company	Period
Chief Financial Officer	Exagen Inc	June 1, 2017 -

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2024-03-06	2024-03-04	Exagen Inc (XGN)	S Sale	3,487 -1.4% 1.91 USD 6,660	3,487 -1.4%	1.91	USD 6,660
2024-03-06	2024-03-04	Exagen Inc (XGN)	S Sale	9,297 -3.6% 1.91 USD 17,747	9,297 -3.6%	1.91	USD 17,747
2024-02-08	2024-02-06	Exagen Inc (XGN)	S Sale	6,738 -3.6% 1.95 USD 13,133	6,738 -3.6%	1.95	USD 13,133
2023-03-03	2023-03-02	Exagen Inc (XGN)	S Sale	3,667 -1.9% 2.30 USD 8,432	3,667 -1.9%	2.30	USD 8,432
2023-02-10	2023-02-08	Exagen Inc (XGN)	S Sale	5,821 -6.0% 2.69 USD 15,671	5,821 -6.0%	2.69	USD 15,671